Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), an international provider of consumer products in cannabis, announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2021 after market close on March 3, 2022.
MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list.
Last week’s Viridian Deal Tracker discussed the recently announced Curaleaf (CSE: CURA) (OTCQX: CURLF) acquisition of integrated Arizona operator Bloom which we view as a leveraged buyout:
In November, Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX: CURLF) reported its third-quarter earnings, revealing a 74% year-over-year increase in revenue to $182.41 million.
MindMed Announces Management Shake-Ups
Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a psychedelic-based biotech company, announced Wednesday that Bradford Cross, its chief technology officer, has transitioned from his role.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) will buy Bloom Dispensaries, a vertically integrated, single state cannabis operator in Arizona, for $211 million in cash.
Marijuana company Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) will buy Natural Remedy Patient Center, LLC, a Safford, Arizona dispensary for $13 million in stock and cash.